以色列 - 希伯来文 - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine

以色列 - 希伯来文 - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 3 g - mesalazine

以色列 - 希伯来文 - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 1 g - mesalazine

以色列 - 希伯来文 - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine

以色列 - 希伯来文 - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - mesalazine (5 - aminosalicylic acid) 3 g - mesalazine

以色列 - 希伯来文 - Ministry of Health

boston scientific isr - רופא - המכשיר מיועד לניתוח מעקפים בלב

以色列 - 希伯来文 - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.

以色列 - 希伯来文 - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); pertactin (prn or 69 kda omp); pertussis toxoid (pt); tetanus toxoid - תרחיף להזרקה - diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid (pt) 8 mcg / 0.5 ml; pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml - tetanus toxoid, combinations with diphtheria toxoid - tetanus toxoid, combinations with diphtheria toxoid - for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of ten years onwards.

以色列 - 希伯来文 - Ministry of Health

ביומדיק טכנולוגיות רפואיות בע"מ - רופא - דופלר להאזנה לדופק העובר

以色列 - 希伯来文 - Ministry of Health

מדיסון פארמה בע"מ - מומחה - עורקים פריפריאלים